Noxafil (Posaconazole)

Posaconazole, the active ingredient in Noxafil, is an azole antifungal presented as a oral formulation for systemic use. It treats invasive fungal infections such as aspergillosis and candidiasis in immunocompromised patients. GNH USA supplies Noxafil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

GNH USA supplies Noxafil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Posaconazole is an azole antifungal that is used to manage serious fungal infections in high‑risk patient groups.

- Invasive aspergillosis: helps prevent or treat the disease by inhibiting fungal growth. - Invasive candidiasis: used for treatment of blood‑borne Candida infections that are resistant to other therapies. - Prophylaxis of fungal infection in hematologic malignancy patients under chemotherapy or stem‑cell transplantation to reduce the risk of invasive mycoses by prevent prevent prevent ...